1 authorised product containing UPADACITINIB, from the HPRA register.
| Medicine | Active substance | Licence holder | Status |
|---|---|---|---|
| RINVOQ 15 mg prolonged-release tablets EU/1/19/1404/001-005 |
UPADACITINIB, Upadacitinib Hemihydrate | AbbVie Deutschland GmbH & Co. KG | — |
Priya Life Science (2026). Irish Medicines Database. Available at: https://priyalifescience.com/medicines (Accessed: 5 July 2026).
Data: Health Products Regulatory Authority (HPRA) open dataset (“Authorised or Transfer Pending Products”), licensed CC BY 4.0, refreshed daily. Regulatory information only — not medical advice.